Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Investa, the UK's first zero-commission options trading app, has been granted direct authorisation by the Financial Conduct Authority (FCA).
-
TARRYTOWN, N.Y., April 20, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows: • BofA Securities Health Care Conference 2026 at...
-
Luxembourg, April 20, 2026 (GLOBE NEWSWIRE) -- OCEANICA LUX, a private limited liability company (société à responsabilité limitée) incorporated and existing under the laws of the Grand Duchy of...
-
Dublin, April 20, 2026 (GLOBE NEWSWIRE) -- The "Data Center Interconnect Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ...
-
TORONTO, April 20, 2026 (GLOBE NEWSWIRE) -- Financial 15 Split Corp. ("Financial 15") declares its regular monthly distribution of $0.12570 for each Class A share ($1.51 annualized) and $0.06042 for...
-
TORONTO, April 20, 2026 (GLOBE NEWSWIRE) -- US Financial 15 Split Corp ("US Financial 15") declares its monthly distribution of $0.06850 for each Preferred share, or 10.00% annually based on the...
-
TORONTO, April 20, 2026 (GLOBE NEWSWIRE) -- North American Financial 15 Split Corp. (The "Company") declares its regular monthly distribution of $0.11335 for each Class A share ($1.3602 annualized)...
-
WEST PALM BEACH, Fla. and TOKYO, April 20, 2026 (GLOBE NEWSWIRE) -- Anthony, Linder & Cacomanolis, PLLC (“ALC”), a premier international capital markets and U.S. securities law firm, provides a...
-
Adds Scaled, Integrated Productivity Solutions Platform with Strong Positions Across Key VerticalsExpands Total Addressable Market and Opens Enterprise Customer ChannelImmediately Double-Digit...
-
WILMINGTON, Del., April 20, 2026 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD) (“Prelude” or the “Company”), a clinical-stage precision oncology company, today announced the...